X

Blog

Lexaria Bioscience Corp. (NASDAQ: LEXX) Banking on DehydraTECH(TM) Technology for Major 2024 Growth

Lexaria, a global innovator in drug delivery platforms, has, since 2016, proven its patented DehydraTECH(TM) technology, asserting its superiority in…

QualityStocks

QualityStocksNewsBreaks – GEMXX Corp.’s (GEMZ) Commitment to Quality, Craftmanship and Market Adaptability Expected to Drive Strong Results

GEMXX (OTC: GEMZ), a mine-to-market gold, gemstone and jewelry producer with global reach, recently announced that it is anticipating strong…

QualityStocks

QualityStocksNewsBreaks – Correlate Energy Corp. (CIPI) Eyes Opportunity Amid Growing Demand for Decentralized Energy Solutions

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is taking advantage…

QualityStocks

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Solutions Offer Greater Online Privacy, Security

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, and its offerings…

QualityStocks

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO for Second DehydraTECH-Powered GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it has hired a contract research…

QualityStocks

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Awarded Two New US Patents Covering Core Cardiac Monitoring Technology

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has received…

QualityStocks

QualityStocksNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Announces New Customer in Sober Living Space

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, has announced a new customer: Breyta House, a sober-living facility…

QualityStocks

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Participation at Upcoming 36th Annual Roth Conference

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., will be represented at…

QualityStocks

19th BioPharma Clinical Trials Nexus Conference to Host Industry Leaders Across Europe And Asia

Top executives, middle-level, and senior managers, working in clinical trial operations, outsourcing, digital health, patient engagement, and allied industries in…

QualityStocks

Bravo Multinational Inc. (BRVO) Is ‘One to Watch’

Bravo, in February 2024, entered an Asset Purchase Agreement to acquire certain assets of Streaming TVEE Inc. in a deal…

QualityStocks